SOUTH SAN FRANCISCO, Calif., Jan. 7, 2024 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 corporate guidance and program updates. 42nd Annual J.P. Morgan Healthcare ConferenceTuesday, January 9th, 2024 […]
SOUTH SAN FRANCISCO, Calif., Dec. 29, 2023 /PRNewswire/ IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today.
SOUTH SAN FRANCISCO, Calif., Dec. 8, 2023 /PRNewswire/ IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today.